Cancer Research UK logo.
SearchDonate
  • Search

A trial of cyclophosphamide and pembrolizumab for kidney cancer (CAPER)

Overview

Cancer types:

Kidney cancer, Secondary cancers

Status:

Closed

Phase:

Phase 1

Details

This trial is looking at a new combination of treatment for kidney cancer that has spread elsewhere in the body or if surgery to remove it is not possible.

It is for people who have already had an immunotherapy.

Recruitment start: 26 January 2021

Recruitment end: 20 July 2023

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Tom Waddell

Supported by

Merck, Sharp & Dohme

The Christie NHS Foundation Trust

Cancer Research UK Manchester Institute Cancer Biomarker Centre

Last reviewed: 23 Jul 2022

CRUK internal database number: 16929

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.